Depression is one of the most common mental health challenges among men in Canada, often going underdiagnosed or undertreated.
At the same time, low testosterone—also known as hypogonadism—is gaining attention as a potential contributor to low mood, fatigue, and motivation loss.
Testosterone replacement therapy (TRT) in Canada has become an increasingly discussed treatment, not only for restoring physical vitality but also for its possible effects on mental well-being.
As awareness grows, so does the need for clear, evidence-based answers: Can TRT really help with depression, or is the hype ahead of the science? This article examines the latest research to explore whether TRT offers genuine relief for depressive symptoms in men—and if so, under what conditions.
Topics covered in this article:
Testosterone plays a vital role in brain function, particularly in areas that regulate mood, energy, and cognitive clarity. When testosterone levels drop—whether due to aging, medical conditions, or other factors—it can trigger a range of psychological symptoms that closely mimic or contribute to depression. Understanding this connection is key to evaluating the role of testosterone replacement therapy (TRT) in mental health care.
Research has shown that testosterone interacts with several brain systems involved in emotional regulation. These include:
These biochemical shifts can result in symptoms such as persistent sadness, irritability, low self-esteem, mental fatigue, and decreased interest in activities—hallmarks of depressive disorders. This overlap explains why many men with low testosterone are misdiagnosed or not fully treated for underlying mood issues.
Multiple clinical trials and meta-analyses have investigated whether testosterone replacement therapy (TRT) can reduce depressive symptoms—especially in men with low testosterone levels. The evidence suggests that TRT may be effective in certain cases, but results vary based on the severity of depression, baseline hormone levels, and the type of study conducted.
A 2019 meta-analysis published in JAMA Psychiatry, which reviewed 27 randomized controlled trials involving over 1,800 men, found that TRT had a moderate but statistically significant antidepressant effect, particularly in men with low or borderline testosterone levels. Another key study from the European Urology Focus journal echoed this, noting that TRT improved mood in men with mild or subclinical depression, especially when hypogonadism was diagnosed.
However, not all research is uniformly positive. A large-scale observational study published in 2022, based on over 70 million U.S. health records, found that men receiving TRT were more likely to be diagnosed with major depressive disorder or experience self-harm events. These findings suggest a potential risk in broader or long-term use, especially among men who do not have a clear medical indication for TRT.
In summary, the most consistent positive outcomes occur in men who have both low testosterone and mild depressive symptoms. The evidence is weaker—and even contradictory—for men with major depressive disorder or those using TRT without clinical hypogonadism.
The impact of testosterone replacement therapy (TRT) on depression depends heavily on the type and severity of symptoms a patient experiences. Clinical research consistently shows that TRT is more effective for men with mild or subthreshold depression—especially when accompanied by confirmed low testosterone levels. In these cases, men often report improvements in mood, energy, and motivation within weeks of starting therapy.
However, for men diagnosed with major depressive disorder (MDD), the evidence is far less convincing. Multiple randomized controlled trials, including those reviewed in European Urology Focus and JAMA Psychiatry, indicate that TRT alone does not reliably alleviate symptoms of MDD. These patients typically require standard psychiatric interventions such as antidepressants or psychotherapy, and TRT is not recommended as a standalone treatment.
Key differences in TRT response by depression type:
This distinction is crucial for clinical decision-making. While TRT can be a useful adjunct in mild cases with hormonal deficiencies, it should not be viewed as a cure for major depression.
Testosterone replacement therapy (TRT) is not a one-size-fits-all solution for mood disorders, but certain groups of men are more likely to experience real benefits when it comes to depressive symptoms. Identifying the right clinical profile is essential for safe and effective treatment.
The men who benefit most from TRT as a mood-enhancing therapy typically fall into these categories:
In these use cases, TRT has been shown to improve emotional stability, motivation, and quality of life when prescribed appropriately. However, treatment should always begin with lab-confirmed low testosterone levels and a full clinical evaluation to rule out other causes of depression.
While testosterone replacement therapy (TRT) may offer mood benefits for some men, it comes with medical risks and ethical limitations that must be taken seriously. TRT can cause a range of side effects, particularly when used without clear clinical need or adequate supervision.
Reported risks and limitations include:
Because of these issues, most medical guidelines—including those in Canada—recommend that TRT be reserved for men with confirmed testosterone deficiency and closely monitored by a healthcare provider. The decision to start TRT should balance potential mood benefits against real physiological risks.
To ensure testosterone replacement therapy (TRT) is both safe and effective for managing depressive symptoms, it must be approached through proper medical channels. That starts with accurate diagnosis, regular monitoring, and a collaborative approach between endocrinology and mental health care.
Best practices include:
In Canada and globally, the emphasis is shifting toward integrated care models where hormone therapy and mental health treatment work together. This reduces the risk of overtreatment and ensures that mood improvements are grounded in both medical and psychological support.
Despite growing interest in testosterone replacement therapy (TRT) as a potential mood treatment, important gaps remain in the clinical evidence. While current studies suggest benefits for certain men—particularly those with low testosterone and mild depression—the research is far from conclusive.
Key areas that future studies need to address include:
In Canada and beyond, there's a growing push for multidisciplinary studies that blend endocrinology, psychiatry, and personalized medicine. Until more definitive data emerges, TRT should be viewed as a targeted tool—not a general treatment—for mood disorders.
TRT may help improve depressive symptoms in men with clinically low testosterone, especially those with mild or subclinical depression. However, it is not considered an effective standalone treatment for major depressive disorder and should only be used under medical supervision.
In Canada, TRT is approved to treat testosterone deficiency—not depression directly. While it may improve mood as a secondary benefit in men with low testosterone, it is not officially indicated for mental health treatment.
Some men report better mood, energy, and motivation within 3 to 6 weeks of starting TRT. However, results vary and depend on baseline testosterone levels, individual response, and coexisting health conditions.
Yes. Potential risks include cardiovascular issues, mood swings, fertility problems, and over-reliance on hormone therapy. It's important to have a confirmed testosterone deficiency and ongoing monitoring by a healthcare provider.
Not automatically. If standard treatments aren't effective, talk to your doctor about checking your testosterone levels. TRT might be a helpful add-on if low testosterone is part of the picture—but it's not a replacement for mental health care.
Symptoms can overlap and include low energy, poor concentration, irritability, reduced sex drive, and a persistent feeling of sadness or lack of motivation. Blood tests are essential to confirm if low testosterone is contributing.
Yes, in men with low testosterone, TRT may improve fatigue, drive, and daily functioning—especially when these symptoms are tied to hormonal imbalance.
Many men report better cognitive function and clearer thinking on TRT, though this varies by individual and isn't guaranteed. These improvements are more likely when low testosterone is clearly documented.
Yes. Low testosterone can contribute to anxiety or emotional instability in some men, while high or fluctuating testosterone levels (especially from unsupervised TRT use) can also trigger mood swings or irritability.
Costs vary by province and formulation (gel, injection, etc.). Some private insurance plans may cover part of the treatment, but coverage depends on the diagnosis and policy terms. It's best to consult your provider and insurer.